What the document says
This is the final report on a medical study in which doctors injected plutonium into hospital patients to learn where it goes in the human body and how fast the body gets rid of it. It is a joint report from the Los Alamos Scientific Laboratory and the Atomic Energy Project at the University of Rochester School of Medicine and Dentistry. The work began under the supervision of the Manhattan Engineer District and was completed under contract for the Atomic Energy Commission. Twelve cases are reported here, correlated with Chicago and Berkeley cases for a total of sixteen.
Subjects were chosen for short life expectancy. As a rule they were past forty-five and ill with chronic disorders such that survival for ten years was highly improbable, which the authors say would avoid late radiation effects and allow post-mortem samples within months. Ten of the twelve were past forty-five. One was eighteen years old. Each person received a single injection of 4.6 to 6.5 micrograms of plutonium as plutonium citrate into an arm vein, on dates from April 10, 1945 to July 16, 1946. Ten of the twelve stayed on a metabolic ward at Strong Memorial Hospital, where urine, feces and blood were collected on a schedule.
Bone and liver took up most of the plutonium. Using bone samples and a 70 kg standard man, the authors estimate 65.7 per cent of the injected dose sits in the skeleton. Liver figures ran higher than animal work predicted, around 20 to 40 per cent of the dose in the first year, with a retention half-time in the liver of a year or more for man against 40 to 60 days for rats. Blood cleared quickly, from 35.7 per cent of the dose at four hours to 0.3 per cent at thirty days. Urine still carried 0.0011 per cent of the dose per day 1610 days after one injection.
Key points
- 01Twelve patients received single intravenous doses of 4.6 to 6.5 micrograms of plutonium, on dates from April 10, 1945 to July 16, 1946.
- 02Subjects were selected for short life expectancy: as a rule past forty-five and chronically ill, so that survival for ten years was highly improbable.
- 03The authors estimate 65.7 per cent of the injected dose goes to the skeleton of a 70 kg man, and that skeleton and liver together hold 90 per cent or more of the total.
- 04Liver uptake in man was much higher than rat experiments predicted, with a plutonium retention half-time in the liver of one year or greater against 40 to 60 days for rats.
- 05Blood levels dropped fast: 35.7 per cent of the dose at four hours, 15.7 per cent at one day, 1.2 per cent at ten days and 0.3 per cent at thirty days.
- 06The report states that acute toxic effects were neither expected nor observed, and that the study gives no evidence of what may happen in 10 to 30 years.
From the original
Obviously the skeletal system and liver are the tissues of major interest when considering the plutonium tolerance, as these two organs alone account for 90 per cent or more of the total plutonium in the entire body.
Source: U.S. Department of Energy, OpenNet declassified document archive, OSTI ID 16290879. The summary is written from the document’s own text. Old scans can be hard to read, so check the original for anything you plan to cite.